Skip to main content
Share On
Donation
Donation period
Choose an option
One-Time
Monthly
Secondary navigation
About Us
News
Events
Blogs
Advocacy
Fundraise
Search
Donate Now
Main navigation
What Is Multiple Myeloma?
Newly Diagnosed
Do You Have Myeloma?
MGUS, Smoldering Myeloma, and Myeloma
Types of Myeloma
Urgent Problems at Diagnosis
FAQ
Tests and Staging
What Tests Do You Need?
Tests to assess blood cells
Tests to assess kidney function
Tests to assess proteins and other substances in the blood
Tests to assess monoclonal protein
Bone marrow tests
Imaging studies
MRD and Mass Spectrometry Testing
Phases of the Disease
What is Durie/Salmon Staging?
International Staging System (ISS) and Revised ISS (R-ISS)
Treatment
What Are First-Line Treatments?
Role of Transplant
Role of Consolidation
Role of Maintenance/Continuous Therapy
What Is Relapse?
Treatment for Early Relapse
Treatment for Subsequent Relapse
Multiple Myeloma Medications
ABECMA® (idecabtagene vicleucel)
AREDIA® (pamidronate disodium)
BLENREP (belantamab mafodotin-blmf)
CARVYKTI (ciltacabtagene autoleucel)
CYTOXAN® (cyclophosphamide)
DARZALEX® (daratumumab)
DARZALEX FASPRO (daratumumab and hyaluronidase-fihj)
Dexamethasone
EMPLICITI® (elotuzumab)
KYPROLIS® (carfilzomib)
Melphalan (ALKERAN®)
NINLARO® (ixazomib)
POMALYST® (pomalidomide)
REVLIMID® (lenalidomide)
Sarclisa (isatuximab-irfc)
TALVEY (talquetamab)
TECVAYLI (teclistamab-cqyv)
THALOMID® (thalidomide)
VELCADE® (bortezomib)
Xgeva (denosumab)
Xpovio (selinexor)
Zometa (zoledronic acid)
Side Effects Management
Anemia
Bone Disease
Distress, Fatigue, and Sexuality
Gastrointestinal Problems
Heart and Lung Complications
Kidney Failure
Myelosuppression
Pain Management
Palliative Care
Peripheral Neuropathy
Steroid Side Effects
Emerging Therapies
Immune Therapy
Clinical Trials
A Clinical Trials Glossary
Clinical Trials Fact Sheets
Long-Term Care Planning
Mobility and safety
Routine health maintenance
Publications and Videos
IMF Publications
Patient Handbook
Understanding Series
Myeloma Minute
Myeloma Today
Tip Cards
Foreign Language Resources
IMF Videos
Black Swan Research Initiative
IMWG Conference Series
Living Well With Myeloma
Patient and Family Seminars
Community Workshop
Nurse Leadership Board Series
Patient Stories - Podcasts
Myeloma Information
Healthcare Professional Resources
IMWG Publications
Nurse Leadership Board Summaries
ASH Abstract Summaries
ASCO Abstract Summaries
CME & Education
Doctors' Edition: Proteasome Inhibitors
Getting Clear Answers to Complex Treatment Challenges in Multiple Myeloma
Resources and Support
IMF Support Network
Find a Support Group
Contact the InfoLine
Care Partner Resources
Find a Clinical Trial
Myeloma Knowledge Platform
Patient and Family Seminars
Regional Community Workshops
Weekly Newsletter
Smart Patients - Community
Mind, Body and Wellness
Patient Blogs from ASH
Diversity, Equity, and Inclusion
Disparities in Healthcare
Disparities in African Americans
Disparities in Hispanic Americans
Disparities in Other Races and Ethnicities in the U.S.
Disparities in Access to Clinical Trials and New Therapies
M-Power Initiative
External Resources
Drug Reimbursement and Co-Pay Assistance Resources
Financial Resources
Government Resources
Counseling and Support Resources
Housing and Travel Resources
International Support
Legal Resources
Pain Management Resources
Transplant Resources
Other Cancer Resources
Our Research
IMF Medical Research
Black Swan Research Initiative
Black Swan Research Projects
Black Swan Publications
Contact the Black Swan Research Initiative
International Myeloma Working Group
International Myeloma Working Group (IMWG) Publications
International Myeloma Working Group (IMWG) Conference Series
Asian Myeloma Network
Multiple Myeloma in Asia
Myeloma Clinical Trials in Asia
Latin American Myeloma Network
Road to the Cure
Nurse Leadership Board
Nurse Leadership Board Members
Nurse Leadership Board Publications
Nursing Resources
Myeloma University
IMF Research Awards
Brian D. Novis Research Grants
Kyle Lifetime Achievement Award
Brian G.M. Durie Outstanding Achievement Award
Ways to Give
Ways to Give
Major Giving
Monthly and Annual Giving
Planned Giving
Corporate Giving
Stock/IRA Donation
Create a Tribute
Other Ways to Give
Start a Fundraiser
Run/Walk Events
Cycling Events
Shop IMF Merchandise
Vehicle Donation
Be An Advocate
U.S. Advocacy
Global Advocacy (GMAN)
Global Myeloma Action Network (GMAN) Annual Summit
Multiple Myeloma: International Bill of Rights
EU Drug Approval and Reimbursement Policy
Veterans Against Myeloma
Myeloma Action Month
About Us
News
Events
Blogs
Advocacy
Fundraise
Donate Now
What is multiple myeloma?
Start Here
Learn more about multiple myeloma
Visit Our Library
No matter the situation, we are here for you
How can we help
The fight against myeloma starts here
The Road to the Cure
Your donation brings us closer to a cure
How Your Gift Helps
Donate
Myeloma Minute
Emerging Therapies
June 5
Top 10 Myeloma Questions Answered: CAR T, New Drugs & Exercise Tips
Emerging Therapies
May 15
Multiple Myeloma Fatigue: A Brief Overview of Disease- and Treatment-Related Tiredness
Emerging Therapies
April 16
CAR T-Cell Therapy Explained in Under 1 Minute | Multiple Myeloma Treatment Breakthroughs
Emerging Therapies
April 10
High-Risk vs. Standard-Risk Multiple Myeloma: What Patients Need to Know in 1 Minute
Emerging Therapies
March 27
Myeloma Patient Questions Answered: Genetic Testing, High-Risk Myeloma, Amyloidosis & More!
Emerging Therapies
March 6
Smoldering Myeloma, Bone Marrow Failure & T-Cell Therapy – Dr. Joe Answers Your Myeloma Questions
Emerging Therapies
February 13
Q&A | Hope for High-Risk Multiple Myeloma: Latest Treatments & Life Expectancy Insights
Emerging Therapies
December 12
How Long Do I Have to Live with Myeloma? In a Minute or Less
Emerging Therapies
November 21
How Clinical Trials Transform Myeloma Care & Survival: Awareness, Trust & Access with Brian McMahon
Emerging Therapies
November 14
AI in Healthcare, Stem Cell Harvesting, Diet, Vaccinations, & More! | Answering Your Myeloma Questions
Emerging Therapies
November 7
Answering Your Top Myeloma Questions: Maintenance Therapy, Imaging, Neuropathy, and More
Emerging Therapies
October 31
What is MGUS? Understanding Monoclonal Gammopathy of Undetermined Significance in Multiple Myeloma
Pagination
Page 1
Next page
››
Subscribe to Emerging Therapies
Give Where Most Needed
$25
$50
$100
$150
$250
Other
Learn More
